Diabetes drug may improve asthma
New biomarker finding strengthens the case for using GLP-1R agonists to treat patients with Type 2 diabetes who also suffer from asthma.
New biomarker finding strengthens the case for using GLP-1R agonists to treat patients with Type 2 diabetes who also suffer from asthma.
Laboratory and administrative personnel at Vanderbilt University Medical Center were honored on March 31 for research excellence during t
Complex conditions and more specialty drugs lead forward-thinking physicians to forge clinical partnerships with pharmacists. Medical centers increasingly grapple with how best to select and monitor patients’ complex medication regimens amid challenges of multiple morbidities and polypharmacy.
The Vanderbilt Diabetes Research and Training Center (DRTC) is celebrating its 49th year of continual operation with the five-year competitive renewal of a $10.9 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH).
In 1973, the Vanderbilt DRTC began its mission to facilitate the discovery, application and translation of scientific knowledge to improve the lives of people with diabetes.
Maureen Gannon, PhD, professor of Medicine, Cell and Developmental Biology, and Molecular Physiology and Biophysics, received the Paul Lacy Medal Award, the highest honor given by the Midwest Islet Club in recognition of meritorious career achievement in the field of islet biology.
Vanderbilt Diabetes Day, an annual event that showcases the work of outstanding scientists and researchers in the fields of diabetes, obesity and metabolism was held this month, and it marked the first time many investigators working under the auspices of the Vanderbilt Diabetes Research and Training Center (DRTC) had gathered in one space since the beginning of the COVID-19 pandemic.